Genomic & Biopharma NewsPost-doc position available – Single cell RNA-Seq of cell models
Salary £31,115 to £39,004pa plus excellent benefits. Two year fixed-term position A postdoctoral position is available at the Wellcome Trust Sanger Institute (WTSI) under the leadership of Dr Martin Hemberg (WTSI) and Dr Rick Livesey (Gurdon Institute). The position provides an exciting opportunity for the successful candidate to create multicellular stem cell-derived models of the ...
|Transcriptome Research & Industry News, 2016-12-06 10:00:11|
Post-doc Positions Available – Epithelial Biology Center
Postdoctoral Fellowship Positions are immediately available within the Vanderbilt University Epithelial Biology Center. The Center is dedicated to the multi-disciplinary study of intra- and extra-cellular trafficking and signaling, establishment and maintenance of epithelial polarity, and role of intestinal stem cells in health and disease. Positions are immediately available in NIH-funded research programs to: characterize gastrointestinal ...
|Exosome RNA Research & Industry News, 2016-12-06 10:00:10|
Researchers develop new compound that can take down defenses in M. tuberculosis
Part of the reason tuberculosis-causing bacteria are so good at colonizing the human body is that they have defenses against the body's immune system.
|News Medical Life Sciences, 2016-12-06 09:23:04|
Creo files for $26M IPO to fund surgical endoscopy devices
Creo files for $26M IPO to fund surgical endoscopy devices nick.paul.taylor Tue, 12/06/2016 - 04:20
|Fierce Biotech, 2016-12-06 09:20:33|
Juno’s reprieve? JCAR017 data a small ray of light after difficult 2016
Juno’s reprieve? JCAR017 data a small ray of light after difficult 2016 badams Tue, 12/06/2016 - 03:54
|Fierce Biotech, 2016-12-06 08:54:16|
New research suggests only 12% of older Americans have dental insurance
Only 12 percent of older Americans have some form of dental insurance and fewer than half visited a dentist in the previous year, suggests new Johns Hopkins Bloomberg School of Public Health research on Medicare beneficiaries.
|News Medical Life Sciences, 2016-12-06 08:52:22|
Experimental T-cell therapy shows promise in preventing AML relapse
Fred Hutchinson Cancer Research Center announced promising results from an early trial in which patients with high-risk acute myeloid leukemia received genetically engineered immune cells.
|News Medical Life Sciences, 2016-12-06 08:46:55|
Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma
The combination of two new drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early-phase study.
|News Medical Life Sciences, 2016-12-06 08:26:19|
AbbVie pens oncology research pacts with academic teams
AbbVie pens oncology research pacts with academic teams nick.paul.taylor Tue, 12/06/2016 - 03:14
|Fierce Biotech, 2016-12-06 08:14:37|